Stocks News

LAST PRICE
512.9950
TODAY'S CHANGE (%)
Trending Down-3.7450 (-0.7247%)

Bid / Lots
512.0200/ 1
Ask / Lots
513.8300/ 6
Open / Previous Close
518.2700 / 516.7400
Day Range
Low 511.1200
High 518.3500
52 Week Range
Low 341.9000
High 519.8800
Volume
69,895
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 6, 2024
- Argus Raises Price Target on Vertex Pharmaceuticals to $550 From $530, from 2:56PM ET on Wednesday Nov 06, 2024 by MT Newswires
  2:56PM ET on Wednesday Nov 06, 2024 by MT Newswires
  Companies Mentioned: VRTX
  02:56 PM EST, 11/06/2024 (MT Newswires) -- Vertex Pharmaceuticals (VRTX) has an average outperform rating and price target range of $325 to $602, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic researc...
- DJ Vertex Pharmaceuticals Is Maintained at Sell by Canaccord Genuity, from 1:08PM ET on Wednesday Nov 06, 2024 by Dow Jones
  1:08PM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: VRTX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/VRTX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 06, 2024 13:08 ET (18:08 GMT)
Nov 5, 2024
- DJ Vertex Pharmaceuticals Is Maintained at Sector Perform by Scotiabank, from 7:00PM ET on Tuesday Nov 05, 2024 by Dow Jones
  7:00PM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: VRTX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/VRTX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 05, 2024 19:00 ET (00:00 GMT)
- Sector Update: Health Care Stocks Rise Tuesday Afternoon, from 2:17PM ET on Tuesday Nov 05, 2024 by MT Newswires
  2:17PM ET on Tuesday Nov 05, 2024 by MT Newswires
  Companies Mentioned: VRTX, MRNA, AZN
  02:17 PM EST, 11/05/2024 (MT Newswires) -- Health care stocks rose Tuesday afternoon with the NYSE Health Care Index up 0.4% and the Health Care Select Sector SPDR Fund (XLV) adding 0.7%. The iShares Biotechnology ETF (IBB) climbed 1.1%. In corporat...
- DJ Vertex Pharmaceuticals Is Maintained at Buy by UBS, from 1:03PM ET on Tuesday Nov 05, 2024 by Dow Jones
  1:03PM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: VRTX
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/VRTX/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 05, 2024 13:03 ET (18:03 GMT)

Today
- Argus Adjusts Price Target on Regeneron Pharmaceuticals to $1,000 From $1,175, from 1 hour ago by MT Newswires
  1 hour ago by MT Newswires
  Companies Mentioned: REGN
Nov 6, 2024
- IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024, from 4:15PM ET on Wednesday Nov 06, 2024 by Dow Jones
  4:15PM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: IQV
- DJ Regeneron Pharma Is Maintained at Outperform by Oppenheimer, from 9:04AM ET on Wednesday Nov 06, 2024 by Dow Jones
  9:04AM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: REGN
- Oppenheimer Adjusts Regeneron Pharmaceuticals Price Target to $1,000 From $1,150, Maintains Outperform Rating, from 8:54AM ET on Wednesday Nov 06, 2024 by MT Newswires
  8:54AM ET on Wednesday Nov 06, 2024 by MT Newswires
  Companies Mentioned: REGN
- Argus Cuts Price Target on IQVIA to $260 From $280, from 7:53AM ET on Wednesday Nov 06, 2024 by MT Newswires
  7:53AM ET on Wednesday Nov 06, 2024 by MT Newswires
  Companies Mentioned: IQV
- Sanofi, Regeneron Receive European Pediatric Approval for Throat Disease Treatment, from 4:13AM ET on Wednesday Nov 06, 2024 by MT Newswires
  4:13AM ET on Wednesday Nov 06, 2024 by MT Newswires
  Companies Mentioned: REGN, SNY
- Dupixent(R) (dupilumab) Approved in the European Union as the First and Only Medicine for Young Children with Eosinophilic Esophagitis, from 1:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
  1:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: REGN, SNY
Nov 5, 2024
- Regeneron Pharmaceuticals Insider Sold Shares Worth $844,610, According to a Recent SEC Filing, from 4:28PM ET on Tuesday Nov 05, 2024 by MT Newswires
  4:28PM ET on Tuesday Nov 05, 2024 by MT Newswires
  Companies Mentioned: REGN
- Argus Cuts Biogen's Price Target to $200 From $250, from 2:14PM ET on Tuesday Nov 05, 2024 by MT Newswires
  2:14PM ET on Tuesday Nov 05, 2024 by MT Newswires
  Companies Mentioned: BIIB
- DJ IQVIA Holdings Price Target Maintained With a $270.00/Share by RBC Capital, from 11:34AM ET on Tuesday Nov 05, 2024 by Dow Jones
  11:34AM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: IQV

Vertex Pharmaceuticals Inc
NASDAQ:VRTXUnited States

Search Criteria

Nov 6, 2024

Argus Raises Price Target on Vertex Pharmaceuticals to $550 From $530, from 2:56PM ET on Wednesday Nov 06, 2024 by MT Newswires

DJ Vertex Pharmaceuticals Is Maintained at Sell by Canaccord Genuity, from 1:08PM ET on Wednesday Nov 06, 2024 by Dow Jones

Nov 5, 2024

DJ Vertex Pharmaceuticals Is Maintained at Sector Perform by Scotiabank, from 7:00PM ET on Tuesday Nov 05, 2024 by Dow Jones

Sector Update: Health Care Stocks Rise Tuesday Afternoon, from 2:17PM ET on Tuesday Nov 05, 2024 by MT Newswires

DJ Vertex Pharmaceuticals Is Maintained at Buy by UBS, from 1:03PM ET on Tuesday Nov 05, 2024 by Dow Jones

Peers Headlines

Today

Argus Adjusts Price Target on Regeneron Pharmaceuticals to $1,000 From $1,175, from 1 hour ago by MT Newswires

Nov 6, 2024

IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024, from 4:15PM ET on Wednesday Nov 06, 2024 by Dow Jones

DJ Regeneron Pharma Is Maintained at Outperform by Oppenheimer, from 9:04AM ET on Wednesday Nov 06, 2024 by Dow Jones

Oppenheimer Adjusts Regeneron Pharmaceuticals Price Target to $1,000 From $1,150, Maintains Outperform Rating, from 8:54AM ET on Wednesday Nov 06, 2024 by MT Newswires

Argus Cuts Price Target on IQVIA to $260 From $280, from 7:53AM ET on Wednesday Nov 06, 2024 by MT Newswires

Sanofi, Regeneron Receive European Pediatric Approval for Throat Disease Treatment, from 4:13AM ET on Wednesday Nov 06, 2024 by MT Newswires

Dupixent(R) (dupilumab) Approved in the European Union as the First and Only Medicine for Young Children with Eosinophilic Esophagitis, from 1:00AM ET on Wednesday Nov 06, 2024 by Dow Jones

Nov 5, 2024

Regeneron Pharmaceuticals Insider Sold Shares Worth $844,610, According to a Recent SEC Filing, from 4:28PM ET on Tuesday Nov 05, 2024 by MT Newswires

Argus Cuts Biogen's Price Target to $200 From $250, from 2:14PM ET on Tuesday Nov 05, 2024 by MT Newswires

DJ IQVIA Holdings Price Target Maintained With a $270.00/Share by RBC Capital, from 11:34AM ET on Tuesday Nov 05, 2024 by Dow Jones